角膜クロスリンキング装置市場レポート：2030年までの動向、予測、競合分析

角膜クロスリンキングデバイスの動向と予測

世界の角膜クロスリンキングデバイス市場は、2024年から2030年までのCAGRが10.2%で、2030年までに推定3億米ドルに達すると予想されています。この市場の主な促進要因は、円錐角膜の有病率の増加と、患者の快適性を向上させる高度なリンキングデバイスに対する需要の高まりです。角膜クロスリンキングデバイスの世界市場の将来は、病院、眼科クリニック、外来手術センター市場における機会によって有望視されています。

角膜クロスリンキング装置市場の洞察

Lucintelは、標準的な角膜クロスリンキングが予測期間中に最も高い成長を遂げると予測しています。

病院は予測期間中に最も高い成長が見込まれます。

アジア太平洋は、強固なヘルスケアインフラが存在し、主要な顧客基盤が存在するため、予測期間中に最も高い成長が見込まれます。

本レポートでは、以下の11の主要な質問に回答しています：

• Q.1.市場セグメントのうち、最も有望かつ高成長な機会は何か？
• Q.2.どのセグメントがより速いペースで成長するのか、またその理由は？
• Q.3.今後成長が加速すると思われる地域とその理由は？
• Q.4.市場力学に影響を与える主な要因は何か？市場における主な課題とビジネスリスクは？
• Q.5.この市場におけるビジネスリスクと競合の脅威は？
• Q.6.この市場における新たな動向とその理由は？
• Q.7.市場における顧客の需要の変化にはどのようなものがありますか？
• Q.8.この市場における新たな開発と、その開発をリードしている企業は？
• Q.9.この市場における主要企業は？主要企業は事業成長のためにどのような戦略的取り組みを進めているのか？
• Q.10.この市場における競合製品にはどのようなものがあり、材料や製品の代替による市場シェア低下の脅威はどの程度ありますか？
• Q.11.過去5年間にどのようなM&Aが行われ、業界にどのような影響を与えましたか？

目次

第1章 エグゼクティブサマリー

第2章 世界の角膜架橋デバイス市場：市場力学

• イントロダクション、背景、分類
• サプライチェーン
• 業界の促進要因と課題

第3章 2018年から2030年までの市場動向と予測分析

• マクロ経済動向（2018～2023年）と予測（2024～2030年）
• 世界の角膜架橋デバイス市場動向（2018-2023）と予測（2024-2030）
• タイプ別の世界の角膜架橋デバイス市場
  • 標準的な角膜架橋
  • 角膜クロスリンキングプラス
  • 加速された架橋
• 方法別の世界の角膜架橋デバイス市場
  • 上皮オフ法
  • 上皮オン法
• 用途別の世界の角膜架橋デバイス市場
  • 円錐角膜
  • 透明辺縁変性
  • 屈折矯正手術エクスタジア
  • その他
• 最終用途別の世界の角膜架橋デバイス市場
  • 病院
  • 眼科クリニック
  • 外来手術センター
  • その他

第4章 2018年から2030年までの地域別の市場動向と予測分析

• 地域別の世界の角膜架橋デバイス市場
• 北米の角膜架橋デバイス市場
• 欧州の角膜架橋デバイス市場
• アジア太平洋角膜クロスリンクデバイス市場
• その他地域角膜架橋デバイス市場

第5章 競合の分析

• 製品ポートフォリオ分析
• 運用上の統合
• ポーターのファイブフォース分析

第6章 成長機会と戦略的分析

• 成長機会分析
  • 種類別の世界の角膜架橋デバイス市場の成長機会
  • 方法別の世界の角膜架橋デバイス市場の成長機会
  • アプリケーション別の世界の角膜架橋デバイス市場の成長機会
  • 最終用途別の世界の角膜架橋デバイス市場の成長機会
  • 地域別の世界の角膜クロスリンクデバイス市場の成長機会
• 世界の角膜架橋デバイス市場の新たな動向
• 戦略的分析
  • 新製品の開発
  • 世界の角膜架橋デバイス市場の能力拡大
  • 世界の角膜架橋デバイス市場における合併、買収、合弁事業
  • 認証とライセンシング

第7章 有力企業の企業プロファイル

• Glaukos
• EMAGine
• Peschke
• IROMED
• iVIS Technologies
• AJL Ophthalmic

Corneal Cross Linking Device Trends and Forecast

The future of the global corneal cross linking device market looks promising with opportunities in the hospital, eye clinic, and ambulaotory surgery center markets. The global corneal cross linking device market is expected to reach an estimated $0.3 billion by 2030 with a CAGR of 10.2% from 2024 to 2030. The major drivers for this market are increased prevalence of keratoconus and rising demand for advanced linking devices to improve patient comfort.

A more than 150-page report is developed to help in your business decisions.

Corneal Cross Linking Device by Segment

The study includes a forecast for the global corneal cross linking device by type, method, application, end use, and region.

Corneal Cross Linking Device Market by Type [Shipment Analysis by Value from 2018 to 2030]:

• Standard Corneal Cross-Linking
• Corneal Cross-Linking Plus
• Accelerated Cross-Linking

Corneal Cross Linking Device Market by Method [Shipment Analysis by Value from 2018 to 2030]:

• Epithelium-Off Method
• Epithelium-On Method

Corneal Cross Linking Device Market by Application [Shipment Analysis by Value from 2018 to 2030]:

• Keratoconus
• Pellucid Marginal Degeneration
• Refractive Surgery Ectasia
• Others

Corneal Cross Linking Device Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

• Hospitals
• Eye Clinics
• Ambulatory Surgical Centers
• Others

Corneal Cross Linking Device Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Corneal Cross Linking Device Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies corneal cross linking device companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the corneal cross linking device companies profiled in this report include-

• Glaukos
• EMAGine
• Peschke
• IROMED
• IVIS Technologies
• AJL Ophthalmic

Corneal Cross Linking Device Market Insights

Lucintel forecasts that standard corneal cross-linking is expected to witness highest growth over the forecast period.

Hospital is expected to witness highest growth over the forecast period.

APAC is expected to witness highest growth over the forecast period due to existence of robust healthcare infrastructure and presence of major customer base in the region.

Features of the Global Corneal Cross Linking Device Market

Market Size Estimates: Corneal cross linking device market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Corneal cross linking device market by various segments, such as by type, method, application, end use and region in terms of($B).

Regional Analysis: Corneal cross linking device market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, methods, applications, end uses, and region.s for the corneal cross linking device market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the corneal cross linking device market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1. What is the corneal cross linking device market size?

Answer: The global corneal cross linking device market is expected to reach an estimated $0.3 billion by 2030.

Q.2. What is the growth forecast for corneal cross linking device market?

Answer: The global corneal cross linking device market is expected to grow with a CAGR of 10.2% from 2024 to 2030.

Q.3. What are the major drivers influencing the growth of the corneal cross linking device market?

Answer: The major drivers for this market are increased prevalence of keratoconus and rising demand for advanced linking devices to improve patient comfort.

Q.4. What are the major segments for corneal cross linking device market?

Answer: The future of the corneal cross linking device market looks promising with opportunities in the hospital, eye clinic, and ambulaotory surgery center markets.

Q.5. Who are the key corneal cross linking device market companies?

Answer: Some of the key corneal cross linking device companies are as follows:

• Glaukos
• EMAGine
• Peschke
• IROMED
• iVIS Technologies
• AJL Ophthalmic

Q.6. Which corneal cross linking device market segment will be the largest in future?

Answer: Lucintel forecasts that standard corneal cross-linking is expected to witness highest growth over the forecast period.

Q.7. In corneal cross linking device market, which region is expected to be the largest in next 5 years?

Answer: APAC is expected to witness highest growth over the forecast period due to existence of robust healthcare infrastructure and presence of major customer base in the region.

Q.8. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the corneal cross linking device market by type (standard corneal cross-linking, corneal cross-linking plus, and accelerated cross-linking), method (epithelium-off method and epithelium-on method), application (keratoconus, pellucid marginal degeneration, refractive surgery ectasia, and others), end use (hospitals, ambulatory surgical centers, eye clinics, and others), and region. (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Corneal Cross Linking Device Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global Corneal Cross Linking Device Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global Corneal Cross Linking Device Market by Type
  • 3.3.1: Standard Corneal Cross-Linking
  • 3.3.2: Corneal Cross-Linking Plus
  • 3.3.3: Accelerated Cross-Linking
• 3.4: Global Corneal Cross Linking Device Market by Method
  • 3.4.1: Epithelium-Off Method
  • 3.4.2: Epithelium-On Method
• 3.5: Global Corneal Cross Linking Device Market by Application
  • 3.5.1: Keratoconus
  • 3.5.2: Pellucid Marginal Degeneration
  • 3.5.3: Refractive Surgery Ectasia
  • 3.5.4: Others
• 3.6: Global Corneal Cross Linking Device Market by End Use
  • 3.6.1: Hospitals
  • 3.6.2: Eye Clinics
  • 3.6.3: Ambulatory Surgical Centers
  • 3.6.4: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global Corneal Cross Linking Device Market by Region
• 4.2: North American Corneal Cross Linking Device Market
  • 4.2.2: North American Corneal Cross Linking Device Market by End Use: Hospitals, Eye Clinics, Ambulatory Surgical Centers, and Others
• 4.3: European Corneal Cross Linking Device Market
  • 4.3.1: European Corneal Cross Linking Device Market by Type: Standard Corneal Cross-Linking, Corneal Cross-Linking Plus, and Accelerated Cross-Linking
  • 4.3.2: European Corneal Cross Linking Device Market by End Use: Hospitals, Eye Clinics, Ambulatory Surgical Centers, and Others
• 4.4: APAC Corneal Cross Linking Device Market
  • 4.4.1: APAC Corneal Cross Linking Device Market by Type: Standard Corneal Cross-Linking, Corneal Cross-Linking Plus, and Accelerated Cross-Linking
  • 4.4.2: APAC Corneal Cross Linking Device Market by End Use: Hospitals, Eye Clinics, Ambulatory Surgical Centers, and Others
• 4.5: ROW Corneal Cross Linking Device Market
  • 4.5.1: ROW Corneal Cross Linking Device Market by Type: Standard Corneal Cross-Linking, Corneal Cross-Linking Plus, and Accelerated Cross-Linking
  • 4.5.2: ROW Corneal Cross Linking Device Market by End Use: Hospitals, Eye Clinics, Ambulatory Surgical Centers, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Corneal Cross Linking Device Market by Type
  • 6.1.2: Growth Opportunities for the Global Corneal Cross Linking Device Market by Method
  • 6.1.3: Growth Opportunities for the Global Corneal Cross Linking Device Market by Application
  • 6.1.4: Growth Opportunities for the Global Corneal Cross Linking Device Market by End Use
  • 6.1.5: Growth Opportunities for the Global Corneal Cross Linking Device Market by Region
• 6.2: Emerging Trends in the Global Corneal Cross Linking Device Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Corneal Cross Linking Device Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Corneal Cross Linking Device Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Glaukos
• 7.2: EMAGine
• 7.3: Peschke
• 7.4: IROMED
• 7.5: iVIS Technologies
• 7.6: AJL Ophthalmic